Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.5.2 and no longer shows Revision: v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check45 days agoChange DetectedNew page revision notes and version identifiers were added, including Revision: v3.4.3 with date 2026-03-05 and additional dates 2027-02, 2026-03-03, and 2026-03. The previous revision v3.4.2 is listed under deletions.SummaryDifference0.4%

- Check73 days agoChange DetectedA new site revision (v3.4.2) has been added, and the older revision (v3.4.1) along with the government funding status notice have been removed. These are administrative page maintenance updates and do not modify study details, eligibility criteria, or results.SummaryDifference0.4%

- Check80 days agoChange DetectedA site-wide notice about potential data inaccuracy due to funding issues has been added, and the page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.